Who invested in Simcha Therapeutics?
Simcha Therapeutics's investors include HSG, Connecticut Innovations, SR One and Samsara BioCapital.

United States · Series B startup
Funding summaryUpdated 26 Oct 2026
$40Mraised across 1 round since 2022, from 1 source
Source recordedSEC filing: $40M sold, first sale Aug 2021
Simcha Therapeutics's investors include HSG, Connecticut Innovations, SR One and Samsara BioCapital.
Simcha Therapeutics has raised $40M across 1 round since 2022.
Simcha Therapeutics's most recent round was a Series B of $40M in Jan 2022.
Its most recent round, $40M in Jan 2022, is also its largest on record.
Simcha Therapeutics's first round on record, in Jan 2022, was backed by HSG, Connecticut Innovations and SR One and 1 others.
Simcha Therapeutics's latest named round is a Series B, in Jan 2022.
Simcha Therapeutics is based in the United States.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.